The startup has developed an AI-assisted biotech platform that enhances high-throughput biological screening for the nutraceutical, microbiome, and pharmaceutical sectors. By minimizing costs and carbon emissions, the platform accelerates the research and development process from early discovery to product potency assessment, leveraging a team with extensive pre-clinical expertise in human wellness.
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional preclinical research and development methods for nutraceuticals, microbiomes, and pharmaceuticals are slow, costly, and often rely on mammalian models, raising ethical and sustainability concerns. Evaluating novel ingredients using these methods can take years and consume significant resources, hindering the pace of innovation.
Solution
NemaLife offers a TechBio platform that accelerates ingredient discovery and validation by leveraging high-throughput, AI-enabled in vivo screening using the C. elegans model. Their patented organism-on-chip technology reduces costs by up to 10x and accelerates product timelines, enabling faster decision-making in the product development process. The platform integrates microfluidics, machine vision, deep neural networks, and cloud databases to provide a comprehensive solution for identifying lead candidates. By using C. elegans, NemaLife reduces reliance on mammalian models, promoting cruelty-free product development and conserving planetary resources.
Target Audience
NemaLife primarily serves companies in the food, nutraceutical, probiotics, and pharmaceutical sectors seeking to accelerate and de-risk their product development pipelines.
Features
- Patented organism-on-chip technology for high-throughput in vivo screening
- AI-enabled platforms for rapid analysis of ingredient effects on worm biology
- Microfluidic chambers for automated worm husbandry and efficient ingredient delivery
- Machine vision and deep neural networks for real-time data extraction and analysis
- Scalable worm husbandry enabling large sample sizes for statistically reliable data
- Validated across a range of ingredient classes, including nutraceuticals, probiotics, and pharmaceuticals
- Reduces reliance on mammalian models, promoting cruelty-free product development
- Discovery and Research Lab services for science-backed validation of novel ingredients